In 2024, the USFDA issued a warning letter to Sun Pharma alleging ‘significant violations’ of ‘current good manufacturing practice’ regulations for pharma made at the same production site in India
Source :- Companies Read More
China halts import, sale of Sun Pharma’s Alzheimer’s drug after inspection
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
August 21, 2026
August 21, 2026
August 20, 2026
